Prot# NBI-34060-MR-0501: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Polysomnographic Study to Assess the Efficacy and Safety of a Modified Release Formulation of NBI-34060 in Primary Insomnia Patients with Sleep Maintenance Difficulties

Project: Research project

Project Details

StatusFinished
Effective start/end date12/20/05 → 3/20/06

Funding

  • PPD Development (NBI-34060-MR-0501)
  • Neurocrine Biosciences, Inc. (NBI-34060-MR-0501)